Impact of a Patient Blood Management monitoring and feedback programme on allogeneic blood transfusions and related costs

A Patient Blood Management programme was established at the University Hospital of Zurich, along with a monitoring and feedback programme, at the beginning of 2014 with a first analysis reported in 2015. Our study aimed to investigate the further impact of this Patient Blood Management monitoring and feedback programme on transfusion requirements and related costs. We included adult patients discharged between 2012 and 2017. A total of 213,882 patients underwent analysis: 66,659 patients in the baseline period (2012–2013); 35,309 patients in the year after the introduction of the Patient Blood Management monitoring and feedback programme (2014) and 111,914 patients in the continued sustainability period (2015–2017). The introduction of the Patient Blood Management monitoring and feedback programme reduced allogeneic blood product transfusions by 35%, from 825 units per 1000 hospital discharges in 2012 to 536 units in 2017. The most sustained effect was an approximately 40% reduction in red blood cell transfusions, from 535 per 1000 discharges to 319 units. Fewer patients were transfused in the periods after the introduction of the Patient Blood Management monitoring and feedback programme (6251 (9.4%) vs. 2932 (8.3%) vs. 8196 (7.3%); p < 0.001). Compared with 2012, the yearly OR for being exposed to any blood transfusion declined steadily after the introduction of the Patient Blood Management monitoring and feedback programme to 0.64 (95%CI 0.61–0.68; p < 0.001) in 2017. For patients requiring extracorporeal membrane oxygenation, transfusion requirements were also sustainably reduced. This reduction in allogeneic blood transfusions led to savings of 12,713,754 Swiss francs (£ 9,497,000 sterling; EUR 11,100,000; US$ 12,440,000) in blood product acquisition costs over 4 years. In‐hospital mortality was not affected by the programme. The Patient Blood Management monitoring and feedback programme sustainably reduced transfusion requirements and related costs, without affecting in‐hospital mortality.

[1]  J. Freedman,et al.  Multimodal Patient Blood Management Program Based on a Three-pillar Strategy: A Systematic Review and Meta-analysis , 2019, Annals of surgery.

[2]  Samuel M. Galvagno,et al.  Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: A cohort study , 2019, Heart & lung : the journal of critical care.

[3]  E. Wood,et al.  Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference , 2019, JAMA.

[4]  P. Meybohm,et al.  A model-based cost-effectiveness analysis of Patient Blood Management. , 2019, Blood transfusion = Trasfusione del sangue.

[5]  Jeong Hoon Yang,et al.  Blood Stream Infection in Patients on Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure , 2018, Infection Control &#x0026; Hospital Epidemiology.

[6]  O. Thom,et al.  Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis. , 2017, The Lancet. Haematology.

[7]  J. Hamdorf,et al.  Improved outcomes and reduced costs associated with a health‐system–wide patient blood management program: a retrospective observational study in four major adult tertiary‐care hospitals , 2017, Transfusion.

[8]  H. Kehlet,et al.  International consensus statement on the peri‐operative management of anaemia and iron deficiency , 2017, Anaesthesia.

[9]  P. Meybohm,et al.  Patient Blood Management Bundles to Facilitate Implementation. , 2017, Transfusion medicine reviews.

[10]  Amy M. Knight,et al.  Relative impact of a patient blood management program on utilization of all three major blood components , 2016, Transfusion.

[11]  S. Ozawa,et al.  Activity‐based costs of plasma transfusions in medical and surgical inpatients at a US hospital , 2016, Vox sanguinis.

[12]  B. Seifert,et al.  Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs , 2015, Transfusion.

[13]  Payam Mohaghegh,et al.  Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients , 2015, Transfusion.

[14]  T. Pawlik,et al.  Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization , 2015, Transfusion.

[15]  J. Isbister,et al.  The three‐pillar matrix of patient blood management , 2015 .

[16]  J. Waters,et al.  Extracorporeal Membrane Oxygenation in the Adult: A Review of Anticoagulation Monitoring and Transfusion , 2014, Anesthesia and analgesia.

[17]  I. Abraham,et al.  The cost of blood transfusion in Western Europe as estimated from six studies , 2012, Transfusion.

[18]  J. Carson,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.

[19]  D. Spahn,et al.  Activity‐based costs of blood transfusions in surgical patients at four hospitals , 2010, Transfusion.

[20]  Hans Gombotz,et al.  Estimating the cost of blood: past, present, and future directions. , 2007, Best practice & research. Clinical anaesthesiology.

[21]  May,et al.  The cost of blood: multidisciplinary consensus conference for a standard methodology. , 2005, Transfusion medicine reviews.